Key result
Implementation of an interventional mitral valve program was associated with a 29.9% increase in surgical mitral valve activity compared to a 9.8% nationwide increase (P=0.09).
Why the study?
Does the implementation of an interventional mitral valve program impact surgical mitral valve activity and the risk profile of surgical patients?
Observational (n=1,382)
Does the implementation of an interventional mitral valve program impact surgical mitral valve activity and the risk profile of surgical patients?
The introduction of an interventional mitral valve program did not reduce surgical volume but rather complemented it by treating a distinct, higher-risk patient population.
Answers are grounded in this paper and cite their sources.
Interventional mitral programs may complement surgical volumes in higher-risk patients; leaves open causal effects and generalizability.
OBJECTIVES: Transcatheter-based treatment of valvular heart disease has increasingly been implemented for the treatment of high-risk patients. The impact of these new treatment modalities on surgical valve programmes is unclear at present. We sought to evaluate the impact of an interventional mitral valve programme on surgical mitral valve activity and to assess the risk profiles of the respective patient populations. METHODS: Between 2007 and 2011, 1112 patients underwent mitral valve surgery for isolated or combined procedures. An interventional mitral valve programme was initiated in 2008, with 270 patients treated from 2008 to 2011. Data were prospectively entered into a database and retrospectively analysed. RESULTS: From 2007 to 2011, surgical mitral valve activity increased by 29.9% compared with a 9.8% increase nationwide (P = 0.09). Compared with the year before the introduction of a MitraClip programme, mean logistic EuroSCORE I of surgical patients was similar in 2011 (2007: 9.4 ± 10.4 vs 2011: 9.5 ± 10.5; P = 0.92), while overall 30-day mortality decreased from 7.2 to 4.4% (P = 0.22). The risk profile of surgical patients decreased significantly regarding several parameters. For isolated mitral valve repair, 30-day mortality was 1.5% (6 of 406) in all patients during the study period. Mean logistic EuroSCORE I of transcatheter patients was significantly higher when compared with that of surgical patients (28.8 ± 18.8 vs 9.5 ± 10.5%; P < 0.01). CONCLUSIONS: Since the implementation of an interventional mitral valve programme, surgical mitral valve activity has increased over the following years. The risk profile of surgical patients decreased regarding several important parameters, although the overall logistic EuroSCORE I remained unchanged. An integrated approach to mitral valve disease with complementary surgical and non-surgical treatment options may possibly help in relieving the undertreatment of patients with severe mitral regurgitation.
No takes yet. Share an insight, caveat, or question.
Conradi et al. (2013) conducted an observational in Mitral valve disease (n=1,382). Interventional mitral valve programme vs. Nationwide surgical activity was evaluated on Increase in surgical mitral valve activity (p=0.09). Implementation of an interventional mitral valve program was associated with a 29.9% increase in surgical mitral valve activity compared to a 9.8% nationwide increase (P=0.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: